Courant.com
HARTFORD TRIAL
Ex-Pfizer Worker Cites Genetically Engineered Virus In Lawsuit Over Firing
By EDMUND H. MAHONY
http://www.courant.com/news/connecticut/hc-pfizer-virus-lawsuit-0314.artmar14,0,1763939.story
The Hartford Courant
March 14, 2010
Medical experts will be watching closely Monday when a scientist who says she has been intermittently paralyzed by a virus designed at the Pfizer laboratory where she worked in Groton opens a much anticipated trial that could raise questions about safety practices in the dynamic field of genetic engineering.
Organizations involved in workplace safety and responsible genetic research already have seized on the federal lawsuit by molecular biologist Becky McClain as an example of what they claim is evidence that risks caused by cutting-edge genetic manipulation have outstripped more slowly evolving government regulation of laboratories.
McClain, of Deep River, suspects she was inadvertently exposed, through work by a former Pfizer colleague in 2002 or 2003, to an engineered form of the lentivirus, a virus similar to the one that can lead to acquired immune deficiency syndrome, or AIDS. Medical experts working for McClain believe the virus has affected the way her body channels potassium, leading to a condition that causes complete paralysis as many as 12 times a month.
"If a worker in a plant as sophisticated as Pfizer is becoming infected with a genetically engineered virus, then I think the potential is everywhere," said Jeremy Gruber, president of the Council for Responsible Genetics, a public interest group created to explore the implications of genetic technologies.
"Genetically engineered viruses are commonly worked on at your average university," Gruber said. "The public has a right to know what regulations are in place and what regulations are required to fix an industrywide issue. We need to have a conversation about this. Ms. McClain's attempt to do that has been hampered at every turn, by the courts and by regulators."
Pfizer disputes all of McClain's claims and says it fired her in 2005 because she refused to come to work. The global pharmaceuticals manufacturer, with research labs in southeastern Connecticut, defends its safety practices and denies that McClain's physical disability is related to exposure at its Groton lab. The company says she did not link her disability to workplace exposure until after she was fired.
As a molecular biologist, McClain studied cells on a molecular level, manipulating genetic codes in an effort to develop vaccines. During the period at issue in the suit, McClain worked in Pfizer's Human Health Embryonic Stem Cells Technologies, Genomic and Proteomic Sciences and Exploratory Medicinal Sciences Group.
Hostile Exchanges
The sharp disagreement between McClain and her former employer mirrors a half-dozen or so years of hostile litigation leading to Monday's jury trial in Hartford before U.S. District Judge Vanessa L. Bryant. McClain will argue that she was wrongfully dismissed and is entitled to unspecified damages. In the run-up, Pfizer attacked McClain's legal claims, and she questioned the company's corporate integrity.
On the advice of her lawyers, McClain would not discuss her suit last week. Neither would her lawyers, nor those representing Pfizer.
But McClain has claimed in her suit and in earlier public statements that she was fired after experiencing symptoms of illness and after complaining to the U.S. Occupational Safety and Health Administration about safety in her Pfizer lab.
OSHA dismissed McClain's complaint. In a decision published after McClain's termination, the agency criticized her for refusing to return to work in spite of "Pfizer's substantial efforts" to address her concerns. In a speech last year to a labor safety group in California, McClain said she was told by an OSHA investigator that the federal agency's legal authority has not kept pace with developments in sophisticated medical research.
A series of angry, pretrial exchanges developed over McClain's efforts to compel Pfizer to give her precise information about the DNA sequencing of the engineered lentivirus she suspects infected her. Pfizer says it responded to all of McClain's requests, in accordance with the law. Her advocates called Pfizer's assertion preposterous and claimed the company has not produced — perhaps because it is subject to trademark — the sequencing data that could enable scientists to engineer a genetic cure.
Over the course of pretrial argument, the number and breadth of McClain's legal claims against Pfizer have been reduced from eight to two. Last month, Bryant dismissed the most significant of the eight claims: that willful and wanton misconduct by Pfizer resulted in lax laboratory procedures. McClain claimed laxity contributed to her exposure.
McClain's advocates point to language in Bryant's ruling that suggests the misconduct allegation was dismissed, at least in part, because state law requires such claims to be resolved by state workers' compensation rules. But Pfizer says Bryant's ruling is another vindication of its assertion that no evidence exists to support McClain's contention that she was infected by a viral exposure at Pfizer.
"We have thoroughly investigated Ms. McClain's claims and our investigation concluded that her workplace was safe and that she was not infected by any virologic materials while she was employed by Pfizer," company spokeswoman Elizabeth Power said.
Bryant's ruling means the trial will move forward under McClain's two remaining claims, both of which involve free speech protection. She says Pfizer fired her in violation of Connecticut's whistle-blower law after she raised questions about Pfizer lab safety to OSHA. And she claims her dismissal also was in retaliation for questions she raised in discussion with Pfizer colleagues about safety practices. In addition to performing her research duties, McClain served on a lab safety committee for at least part of the nine years she was employed by Pfizer.
Medical Evidence
Pfizer has taken the position that Bryant's ruling in March means no evidence will be admitted at the trial concerning McClain's health or her claim that it was destroyed by bad lab procedures. McClain's advocates, again, disagree. Because McClain is suing under a whistle-blower claim, they believe she will be allowed to present evidence about why she figuratively blew the whistle. If her health and safety are the reasons, they say, the judge could allow jurors to hear evidence in those areas.
In her suit, McClain says that Pfizer hired her in 1995 and that, in 2000, she became involved in human cellular research associated with vaccine development. She later learned, the suit says, that colleagues in her lab were working with infectious, genetically engineered viruses, including the lentivirus she suspects causes what her physician calls "acute intermittent paralysis."
The suit describes lab events that McClain suggests could have infected her.
The first involved the possible malfunction of a "laminar hood," a system designed to contain materials being subjected to scientific manipulation and to purify the air circulating around the materials. She said the hood began emitting a noxious odor at the same time she and several colleagues developed symptoms of illness, including nausea.
McClain said in the suit that, as a member of the lab safety committee, she reported the apparent hood malfunction. Judge Bryant said in a preliminary ruling that Pfizer took "various steps" to fix the hood and ultimately replaced it, twice.
Pfizer contends that the hood problem was resolved eight months after McClain reported it. But a long e-mail message by one of McClain's supervisors and the OSHA review corroborate McClain's contention that the problem persisted for a year. Before it was corrected, several people suffered from headaches, vomiting and nausea, including at least one member of the crew that cleaned the lab after work.
About two months after the hood problem was resolved, McClain says in the suit, she learned from a colleague that he was working "next to" her on "dangerous lentivirus material and embryonic stem cells." The work was being done on an open lab bench, unprotected by a biological containment system, the suit says, even though lentivirus work should have been done only under a protective "biological hood."
"I was shocked and appalled to find he had been using lentivirus materials on an open lab bench without biocontainment where I performed my office work (e.g. without gloves) in October 2003," McClain wrote in a legal filing.
On another occasion, she says, she encountered an unidentified experimental set-up consisting of cell cultures on her laboratory bench, but she cannot recall whether she touched it.
Pfizer has responded that any lentivirus studied in lab areas where McClain was present was not derived from a human infectious virus and was not infectious because it lacked genes for replication.
McClain says in the suit that she repeatedly raised laboratory safety issues following the hood malfunction, despite a warning from a supervisor that doing so could jeopardize her employment. She said she began suffering from "fatigue, suspicion of multiple sclerosis, joint pain, and numbness in her face as well as sleep difficulties" and took a medical leave in February 2004. She was fired about 11 months later.
The suit contends the dismissal was retaliation for her complaints about safety. In a speech a year ago, McClain asserted that some of the safety deficiencies she has criticized are the product of poor lab design — design that is nonetheless acceptable under OSHA rules.
Pfizer contends that McClain's dismissal was not related to her concern about safety. Rather, the company says, she was terminated for refusing to report back to work after the company made her repeated offers, including alternative employment opportunities, some in laboratories other than the one about which she had complained. Pfizer claims McClain was told in advance of her termination that she would be fired if she didn't return to work.
Even though jurors are unlikely to hear arguments that McClain's potassium disorder and related transient paralysis are attributable to exposure to an engineered virus, a network of laboratory safety advocates already is using the case as a rallying point. A group from San Francisco has planned a press conference outside the Hartford courthouse on Main Street at 12:15 p.m. Monday.
They say OSHA's inability to stay abreast of developments in sophisticated, molecular research techniques — as well as law protecting the confidentiality of proprietary discoveries — has neutralized the agency's ability to act as an effective regulator.
"This case shows a major flaw for workers in the biotech industry who have to prove where they got injured in order to receive workers' compensation," said Steve Zeltzer, one of the organizers.
Copyright © 2010, The Hartford Courant
Showing posts sorted by relevance for query pfizer. Sort by date Show all posts
Showing posts sorted by relevance for query pfizer. Sort by date Show all posts
Sunday, March 14, 2010
Injured Biotech Worker Sues Pfizer
Sunday, April 1, 2012
SAFETY IN THE BIOTECH INDUSTRY
THE NEW LONDON DAY
Whistleblower now reluctant biotech safety spokeswoman
By Lee Howard
Publication: The Day http://www.theday.com/article/20120401/BIZ02/304019913/1018


Former Pfizer Inc. molecular biologist Becky McClain calls herself a "reluctant activist" now that she has become a national spokeswoman for biotech safety after winning a $1.37 million judgment two years ago against her former employer.
"I'm a scientist," the Deep River resident said. "I'm not schooled in public speaking."
But McClain, who won a jury award on April 1, 2010, against Pfizer after being fired following a series of safety complaints and what she says was exposure to a novel virus at the pharmaceutical giant's Groton laboratories, has been taking speaking engagements around the country to inform the public about the dangers of unregulated biotech laboratories.
In 2010, she received a Civic Courage award from a group associated with consumer activist Ralph Nader. She also is on the board of the Alliance for Humane Biotechnology, which advocates for better safety conditions at laboratories, and serves as executive director of the Injured Workers National Network.
"We've got a serious public health and safety issue that's not being addressed," she said. "It's like a horrible weight on my shoulder."
Just last week, she flew to California to speak at the Center For Genetics and Society in Berkeley about synthetic biology - a technique that enables scientists to engineer artificial life forms from scratch - which she sees as a new threat to public safety.
McClain claims to have been exposed to a dangerous virus while working at a Pfizer lab in Groton, and has spent nearly a decade fighting a condition that she says sends her into periodic bouts of paralysis - though symptoms are less severe today than they were at the beginning.
"Becky provides a cautionary tale for the kinds of releases of organisms we can expect to see more of in the future," said Jeff Conant, communications director for the Global Justice Ecology Project, one of the groups that invited her to speak in California.
"The problem is the public doesn't understand ... that the regulatory framework failed," McClain said. "They think, 'Oh, we're protected because she won $1.37 million.'"
McClain has yet to see a dime from her court victory as Pfizer has appealed the jury verdict.
The case became bogged down in February 2011 when Judge Vanessa L. Bryant, who had presided over the two-week trial at U.S. District Court in Hartford, acknowledged that she had a conflict of interest. Her husband, attorney Tracy L. Rich, had hired the Hartford-based Jackson Lewis law firm - the same counsel that argued Pfizer's case in court against McClain - to represent Guardian Life Insurance Co., which he served as general counsel and executive vice president, according to court documents.
Judge Warren Eginton took over the case and, in June of last year, issued a ruling that Pfizer owed McClain an additional $450,000 for attorney's fees and nearly $460,000 for punitive damages.
In the ruling, Eginton backed the jury's decision, saying that it reasonably concluded that "Pfizer terminated McClain because she made statements about matters of public concern" and that McClain's complaints about worker safety "did not interfere with her job performance."
Pfizer said it is disputing the jury decision because McClain was fired for abandoning her job rather than for exercising her right to free speech.
"It was undisputed during trial that Ms. McClain was able to work but chose not to for close to a year and only after leaving her job open for that period did Pfizer terminate her employment," the company said in a statement last week.
The judge's ruling brought McClain's total award to about $2.3 million. McClain was represented by Steve Fitzgerald of New Haven and Bruce Newman of Bristol, two of the few attorneys, she said, who were willing to take on Pfizer.
Pfizer appealed the ruling to the U.S. Second Circuit Court of Appeals, and McClain says it could be another year or more before the case is decided. McClain says she is hardly bitter, however, noting the court system gave her a more favorable hearing than she found from Pfizer or regulatory agencies such as the Occupational Safety and Health Administration.
"It's the only place I found some justice," she said.
Still, McClain says taking whistleblower complaints through the federal court system isn't the best way to address issues affecting public health and safety because justice takes too long.
"We need whistleblower laws that are efficient and swift, since the advanced technologies ... can be dangerous and can pose a significant and immediate threat to the public," she said.
Safeguards defended
McClain's appearance last week in California coincided with the planned expansion of the Lawrence Berkeley National Laboratory to Richmond, Calif., a billion-dollar venture funded partially with public money that potentially would create the world's largest synthetic biotech lab. The lab is at the epicenter of the synthetic-biology controversy because of the rapid growth of private biotech companies in California.
While synthetic biology has applications in the pharmaceutical field, fossil-fuel companies are beginning to invest in the process, hoping to develop a new generation of biofuels.
The industry is largely self-regulated, according to opponents, with neither the U.S. Food and Drug Administration nor the Environmental Protection Agency regulating the creation of new life forms.
"The risks that this rapidly growing field poses to worker safety, public health, social justice and the environment are poorly understood, and effectively unregulated," according to a group of ecological and worker-safety advocates that sponsored the forum, believed to be the first ever assembled by people not directly tied to the industry.
Supporters of the lab quoted in the San Francisco Chronicle last week insist it is safe.
"The whole point of synthetic biology is to make every step in the process more predictable and more reliable," said Jay D. Keesling, founder of the Berkeley lab's synthetic biology department.
Likewise, Pfizer said in a statement that it has a robust system in place to ensure compliance with environmental health and safety regulations.
"We have an active biological safety network, comprised of experienced biosafety professionals from across the company, that establishes and progresses biosafety program objectives for the company including robust risk assessment and management," Pfizer said.
Pfizer fought McClain for years in court over releasing records that would indicate the kind of virus to which she was exposed, with the company claiming the documents contained trade secrets. A judge eventually ordered Pfizer to release the exposure records, at which time the company said it couldn't locate them, McClain said, though Pfizer in court documents says it has released everything in its possession and even has allowed McClain and one of her attorneys to perform an on-site inspection in search of records.
"Pfizer has never claimed that they 'no longer have' records that Ms. McClain requested," the company said. "The issue is that while Ms. McClain has demanded 'exposure records,' no such records exist because she was not exposed to anything at Pfizer that caused her any injury."
Settlement offer rejected
McClain said the ability of Pfizer to deny the existence of the virus she says caused her harm only exposes the problem of allowing the biotech industry to police itself.
"We were at risk to exposure that could cause us harm," McClain said in her speech last week in California. "We also were at risk to carry an infectious agent out into the public."
McClain has campaigned over the past two years for more rigorous regulation of the country's booming biotech industry, which Gov. Dannel P. Malloy has been trying to tap into as a way of boosting the state's business climate. She decries the way academics are now constrained from criticizing the biotech industry because of university-corporate partnerships in "translational science" that fund research to discover new drugs.
"When a whistleblower or injured worker tries to confront an industry (safety issue), they run into a roadblock from every aspect," she said. "Pfizer has infiltrated almost every major university in the country."
McClain said she marches on as an advocate for worker safety, despite an aversion to public speaking and the fact that all of her expenses usually are not covered by the groups who want to hear her story. But she feels she must continue to speak out, and has rejected several offers by Pfizer to settle her case out of court because of the "gag order" that she says likely would result from taking the company's money.
"If I had not gotten sick, I wonder if I ever would have gone through this," she said.
With so few avenues left to get her message across, McClain said her best hope is for the public to begin protesting, as occurred earlier this year when eight people from the Occupy movement were arrested outside Pfizer's Groton laboratories.
"The government is no longer going to protect you," she said, "that's why the community has to get involved."
l.howard@theday.com
Visit The Day website to comment http://www.theday.com/article/20120401/BIZ02/304019913/1018
Whistleblower now reluctant biotech safety spokeswoman
By Lee Howard
Publication: The Day http://www.theday.com/article/20120401/BIZ02/304019913/1018
Published 04/01/2012 12:00 AM
Updated 04/01/2012 12:04 AM
Dana Jensen/The Day
Becky McClain, a former Pfizer scientist who won a $1.37 million lawsuit against the company after becoming ill on the job but has not received any of the money, sits in her home last week. Pfizer is fighting the decision in the 2nd Circuit Court of Appeals.
Dana Jensen/The Day
Becky McClain, a former Pfizer scientist who won a $1.37 million lawsuit against the company after becoming ill on the job but has not received any of the money, sits in her home last week. Pfizer is fighting the decision in the 2nd Circuit Court of Appeals.
1
1
Former Pfizer Inc. molecular biologist Becky McClain calls herself a "reluctant activist" now that she has become a national spokeswoman for biotech safety after winning a $1.37 million judgment two years ago against her former employer.
"I'm a scientist," the Deep River resident said. "I'm not schooled in public speaking."
But McClain, who won a jury award on April 1, 2010, against Pfizer after being fired following a series of safety complaints and what she says was exposure to a novel virus at the pharmaceutical giant's Groton laboratories, has been taking speaking engagements around the country to inform the public about the dangers of unregulated biotech laboratories.
In 2010, she received a Civic Courage award from a group associated with consumer activist Ralph Nader. She also is on the board of the Alliance for Humane Biotechnology, which advocates for better safety conditions at laboratories, and serves as executive director of the Injured Workers National Network.
"We've got a serious public health and safety issue that's not being addressed," she said. "It's like a horrible weight on my shoulder."
Just last week, she flew to California to speak at the Center For Genetics and Society in Berkeley about synthetic biology - a technique that enables scientists to engineer artificial life forms from scratch - which she sees as a new threat to public safety.
McClain claims to have been exposed to a dangerous virus while working at a Pfizer lab in Groton, and has spent nearly a decade fighting a condition that she says sends her into periodic bouts of paralysis - though symptoms are less severe today than they were at the beginning.
"Becky provides a cautionary tale for the kinds of releases of organisms we can expect to see more of in the future," said Jeff Conant, communications director for the Global Justice Ecology Project, one of the groups that invited her to speak in California.
"The problem is the public doesn't understand ... that the regulatory framework failed," McClain said. "They think, 'Oh, we're protected because she won $1.37 million.'"
McClain has yet to see a dime from her court victory as Pfizer has appealed the jury verdict.
The case became bogged down in February 2011 when Judge Vanessa L. Bryant, who had presided over the two-week trial at U.S. District Court in Hartford, acknowledged that she had a conflict of interest. Her husband, attorney Tracy L. Rich, had hired the Hartford-based Jackson Lewis law firm - the same counsel that argued Pfizer's case in court against McClain - to represent Guardian Life Insurance Co., which he served as general counsel and executive vice president, according to court documents.
Judge Warren Eginton took over the case and, in June of last year, issued a ruling that Pfizer owed McClain an additional $450,000 for attorney's fees and nearly $460,000 for punitive damages.
In the ruling, Eginton backed the jury's decision, saying that it reasonably concluded that "Pfizer terminated McClain because she made statements about matters of public concern" and that McClain's complaints about worker safety "did not interfere with her job performance."
Pfizer said it is disputing the jury decision because McClain was fired for abandoning her job rather than for exercising her right to free speech.
"It was undisputed during trial that Ms. McClain was able to work but chose not to for close to a year and only after leaving her job open for that period did Pfizer terminate her employment," the company said in a statement last week.
The judge's ruling brought McClain's total award to about $2.3 million. McClain was represented by Steve Fitzgerald of New Haven and Bruce Newman of Bristol, two of the few attorneys, she said, who were willing to take on Pfizer.
Pfizer appealed the ruling to the U.S. Second Circuit Court of Appeals, and McClain says it could be another year or more before the case is decided. McClain says she is hardly bitter, however, noting the court system gave her a more favorable hearing than she found from Pfizer or regulatory agencies such as the Occupational Safety and Health Administration.
"It's the only place I found some justice," she said.
Still, McClain says taking whistleblower complaints through the federal court system isn't the best way to address issues affecting public health and safety because justice takes too long.
"We need whistleblower laws that are efficient and swift, since the advanced technologies ... can be dangerous and can pose a significant and immediate threat to the public," she said.
Safeguards defended
McClain's appearance last week in California coincided with the planned expansion of the Lawrence Berkeley National Laboratory to Richmond, Calif., a billion-dollar venture funded partially with public money that potentially would create the world's largest synthetic biotech lab. The lab is at the epicenter of the synthetic-biology controversy because of the rapid growth of private biotech companies in California.
While synthetic biology has applications in the pharmaceutical field, fossil-fuel companies are beginning to invest in the process, hoping to develop a new generation of biofuels.
The industry is largely self-regulated, according to opponents, with neither the U.S. Food and Drug Administration nor the Environmental Protection Agency regulating the creation of new life forms.
"The risks that this rapidly growing field poses to worker safety, public health, social justice and the environment are poorly understood, and effectively unregulated," according to a group of ecological and worker-safety advocates that sponsored the forum, believed to be the first ever assembled by people not directly tied to the industry.
Supporters of the lab quoted in the San Francisco Chronicle last week insist it is safe.
"The whole point of synthetic biology is to make every step in the process more predictable and more reliable," said Jay D. Keesling, founder of the Berkeley lab's synthetic biology department.
Likewise, Pfizer said in a statement that it has a robust system in place to ensure compliance with environmental health and safety regulations.
"We have an active biological safety network, comprised of experienced biosafety professionals from across the company, that establishes and progresses biosafety program objectives for the company including robust risk assessment and management," Pfizer said.
Pfizer fought McClain for years in court over releasing records that would indicate the kind of virus to which she was exposed, with the company claiming the documents contained trade secrets. A judge eventually ordered Pfizer to release the exposure records, at which time the company said it couldn't locate them, McClain said, though Pfizer in court documents says it has released everything in its possession and even has allowed McClain and one of her attorneys to perform an on-site inspection in search of records.
"Pfizer has never claimed that they 'no longer have' records that Ms. McClain requested," the company said. "The issue is that while Ms. McClain has demanded 'exposure records,' no such records exist because she was not exposed to anything at Pfizer that caused her any injury."
Settlement offer rejected
McClain said the ability of Pfizer to deny the existence of the virus she says caused her harm only exposes the problem of allowing the biotech industry to police itself.
"We were at risk to exposure that could cause us harm," McClain said in her speech last week in California. "We also were at risk to carry an infectious agent out into the public."
McClain has campaigned over the past two years for more rigorous regulation of the country's booming biotech industry, which Gov. Dannel P. Malloy has been trying to tap into as a way of boosting the state's business climate. She decries the way academics are now constrained from criticizing the biotech industry because of university-corporate partnerships in "translational science" that fund research to discover new drugs.
"When a whistleblower or injured worker tries to confront an industry (safety issue), they run into a roadblock from every aspect," she said. "Pfizer has infiltrated almost every major university in the country."
McClain said she marches on as an advocate for worker safety, despite an aversion to public speaking and the fact that all of her expenses usually are not covered by the groups who want to hear her story. But she feels she must continue to speak out, and has rejected several offers by Pfizer to settle her case out of court because of the "gag order" that she says likely would result from taking the company's money.
"If I had not gotten sick, I wonder if I ever would have gone through this," she said.
With so few avenues left to get her message across, McClain said her best hope is for the public to begin protesting, as occurred earlier this year when eight people from the Occupy movement were arrested outside Pfizer's Groton laboratories.
"The government is no longer going to protect you," she said, "that's why the community has to get involved."
l.howard@theday.com
Visit The Day website to comment http://www.theday.com/article/20120401/BIZ02/304019913/1018
Thursday, April 1, 2010
PUBLIC HEALTH & SAFETY IN BIOTECH INDUSTRY
Pfizer's, scientist's lawyers duel over safety standards "McClain's employment came to an effective end after she filed an OSHA complaint in January 2005."
http://www.theday.com/article/20100401/BIZ02/304019462/1044
Pfizer's, scientist's lawyers duel over safety standards
By Lee Howard
Publication: The Day
Published 04/01/2010
Jury gets case in federal trial seeking damages
Hartford - A jury in the first federal civil trial involving a biotech worker who claims to have been injured on the job spent about two hours in deliberations Wednesday at U.S. District Court before retiring for the day without reaching a verdict.
Earlier in the day, attorneys for Pfizer and former company scientist Becky McClain of Deep River clashed over the importance of the pharmaceutical giant's decision to vent possibly contaminated air into the atmosphere near its Groton research center.
Pfizer's attorney, William Anthony, told jurors during closing arguments in the three-week trial that filters used in conjunction with the venting had eliminated nearly all the impurities that caused a noxious odor - an odor that, according to testimony, became noticeable shortly before several people in the lab fell sick. He added that references to the incident from McClain's attorneys amounted to a "shameless attempt to incite you."
But McClain's attorney, Steve Fitzgerald, argued in a rebuttal that the decision to vent the air - which backers of McClain claim could have contained a dangerous experimental virus - "speaks to Pfizer's approach to safety issues." He said "there's a corporate culture at Pfizer" that "we decide what's safe … (and) the measure of what's safe is what's legal."
McClain, who has claimed she was infected by a dangerous virus while working at Lab B313 on Pfizer's Groton campus, said in her federal suit that the company retaliated against her for filing safety complaints with the U.S. Occupational Safety and Health Administration. She is also maintaining that her free-speech rights were violated because she was fired after raising safety concerns about the lab layout in Groton, in which desks where scientists type and benches as which they conduct experiments are side by side.
But Anthony said Pfizer did not retaliate against McClain. Instead, he argued, Pfizer executives thanked McClain for her safety complaints and eventually offered her a transfer to another lab - an offer McClain's attorneys have denied ever happened.
Anthony said Pfizer begged McClain to come back to work but she refused.
"Pfizer didn't abandon her," he said. "Ms. McClain didn't want to come back."
Fitzgerald, however, said McClain's employment came to an effective end after she filed an OSHA complaint in January 2005. He charged that her supervisor earlier had threatened to falsify McClain's annual review and that her subsequent poor appraisal rating demonstrated Pfizer management had conspired against her.
McClain's claims for lost wages and benefits total more than $2 million, but the jury could add to the total if it decides to award punitive damages as well.
The case Becky McClain v. Pfizer Inc. has been closely watched by workers' rights organizations as well as the legal community. They see the case as a test for whether safety
complaints against biotech firms can be successfully argued when the connection between tiny biological organisms and employee injuries are so difficult to pinpoint.
McClain's case was made particularly cumbersome, according to workers' rights groups, when Judge Bryant at the last minute threw out the most central charge - that Pfizer had shown wanton and reckless disregard for McClain's safety by exposing her to an experimental virus that caused serious health problems and prevented her from working.
l.howard@theday.com
http://www.theday.com/article/20100401/BIZ02/304019462/1044
Pfizer's, scientist's lawyers duel over safety standards
By Lee Howard
Publication: The Day
Published 04/01/2010
Jury gets case in federal trial seeking damages
Hartford - A jury in the first federal civil trial involving a biotech worker who claims to have been injured on the job spent about two hours in deliberations Wednesday at U.S. District Court before retiring for the day without reaching a verdict.
Earlier in the day, attorneys for Pfizer and former company scientist Becky McClain of Deep River clashed over the importance of the pharmaceutical giant's decision to vent possibly contaminated air into the atmosphere near its Groton research center.
Pfizer's attorney, William Anthony, told jurors during closing arguments in the three-week trial that filters used in conjunction with the venting had eliminated nearly all the impurities that caused a noxious odor - an odor that, according to testimony, became noticeable shortly before several people in the lab fell sick. He added that references to the incident from McClain's attorneys amounted to a "shameless attempt to incite you."
But McClain's attorney, Steve Fitzgerald, argued in a rebuttal that the decision to vent the air - which backers of McClain claim could have contained a dangerous experimental virus - "speaks to Pfizer's approach to safety issues." He said "there's a corporate culture at Pfizer" that "we decide what's safe … (and) the measure of what's safe is what's legal."
McClain, who has claimed she was infected by a dangerous virus while working at Lab B313 on Pfizer's Groton campus, said in her federal suit that the company retaliated against her for filing safety complaints with the U.S. Occupational Safety and Health Administration. She is also maintaining that her free-speech rights were violated because she was fired after raising safety concerns about the lab layout in Groton, in which desks where scientists type and benches as which they conduct experiments are side by side.
But Anthony said Pfizer did not retaliate against McClain. Instead, he argued, Pfizer executives thanked McClain for her safety complaints and eventually offered her a transfer to another lab - an offer McClain's attorneys have denied ever happened.
Anthony said Pfizer begged McClain to come back to work but she refused.
"Pfizer didn't abandon her," he said. "Ms. McClain didn't want to come back."
Fitzgerald, however, said McClain's employment came to an effective end after she filed an OSHA complaint in January 2005. He charged that her supervisor earlier had threatened to falsify McClain's annual review and that her subsequent poor appraisal rating demonstrated Pfizer management had conspired against her.
McClain's claims for lost wages and benefits total more than $2 million, but the jury could add to the total if it decides to award punitive damages as well.
The case Becky McClain v. Pfizer Inc. has been closely watched by workers' rights organizations as well as the legal community. They see the case as a test for whether safety
complaints against biotech firms can be successfully argued when the connection between tiny biological organisms and employee injuries are so difficult to pinpoint.
McClain's case was made particularly cumbersome, according to workers' rights groups, when Judge Bryant at the last minute threw out the most central charge - that Pfizer had shown wanton and reckless disregard for McClain's safety by exposing her to an experimental virus that caused serious health problems and prevented her from working.
l.howard@theday.com
Friday, April 2, 2010
BIOTECH WORKER AWARDED COMPENSATION
Jury awards ex-Pfizer scientist $1.37 million
By Lee Howard
Publication: The Day
Published 04/02/2010
Becky McClain, of Deep River, a former Pfizer scientist, won a $1.37 million judgment from a U.S. District Court jury, which found that she had been unfairly terminated after raising safety concerns.
http://www.theday.com/article/20100402/NWS02/304029903
Biotech safety verdict is hailed as a milestone; company weighs options
Becky McClain, a Deep River scientist who claims to have been infected by an experimental virus while working at Pfizer Inc.'s Groton laboratories, was awarded $1.37 million Thursday by a U.S. District Court jury in Hartford that found the company had retaliated against her and interfered with the fired worker's right to free speech.
The amount McClain receives could increase thanks to the jury's decision to also award punitive damages. The amount is up to Judge Vanessa Bryant, but typically in Connecticut punitive damages would include McClain's attorneys' fees plus an additional amount equal to the legal bills - pushing Pfizer's total penalty to more than $2.25 million.
Workers' rights organizations hailed the verdict, saying the outcome of the federal civil suit was a major milestone for biotech and nanotech workers.
"The fact that the largest drug company in the world has such contempt for the protection of their thousands of scientists is a stark warning that the present protective laws are not being enforced and need to be seriously strengthened," said Steve Zeltzer, chair of the California Coalition For Workers Memorial Day, a group that advocates for employees hurt on the job.
Pfizer continues to deny all of the suit's charges and said Thursday that the company is considering its legal options.
"We are disappointed with the verdict and do not believe the facts of this case warrant the conclusion reached by the jury," Pfizer said in an e-mailed statement.
"Pfizer is committed to protecting the health and safety of our colleagues and the communities in which we operate," the statement continued.
"In addition to our commitment to full compliance with environmental, health and safety laws and regulations, we have company-wide policies, standards, and programs combined with site-level management systems and initiatives tailored to the particular safety issues and needs at each location."
Pfizer previously said it had thoroughly investigated McClain's health and safety claims and found them to be untrue.
The suit, argued during a three-week trial before Bryant, has been followed by labor organizations, attorneys and members of the medical and research community because it is the first federal case involving a biotech worker who claims to have been harmed by a novel virus while on the job.
Workers' rights groups have criticized Bryant for throwing out McClain's major claim shortly before the trial began. The claim was that Pfizer engaged in willful and wanton misconduct in exposing her to a dangerous work environment that led to health problems, including bouts of temporary paralysis.
"The failure of the top company officials to even report to OSHA and other government agencies that many workers were getting sick numerous times in their laboratories ... is inexcusable," said Zeltzer, who called on state and federal authorities to open a criminal investigation into what he called a "cover-up" of health and safety violations at Pfizer.
McClain, a molecular biologist who first filed her suit about three years ago in New London Superior Court, had claimed that Pfizer violated whistleblower laws. A former member of the company's safety committee, McClain also charged that Pfizer violated her freedom of speech by terminating her after she pressed complaints with the U.S. Occupational Safety and Health Administration.
McClain, through her New Haven attorney Steve Fitzgerald, said in a statement that she hopes the verdict opens up a national discussion about the dangers of exposure to potentially life-threatening substances in the biotech workplace and the right of scientists and technicians to have a safe work environment.
"I was very pleased the jury found that Pfizer did retaliate against me for speaking about unsafe conditions at the Groton lab and for making a report to OSHA," McClain said. "I am disappointed, however, that I have not yet received exposure records from Pfizer" that could have identified the virus she was exposed to and provided an avenue for determining proper medical care.
Another of McClain's attorneys, Bruce E. Newman of Bristol, has called the case precedent-setting because there are few government standards regulating the bioengineering field. Worker-safety groups say OSHA regulations haven't kept up with fast-evolving technical occupations, saying the agency doesn't employ people with enough knowledge of safety problems in certain highly skilled fields.
McClain, who worked at Pfizer for nearly a decade before being terminated in 2005, was employed in Groton's embryonic stem cells program when she said she became ill after being subjected to repeated noxious fumes coming from the hood of a device at Lab B313, according to her suit. Her supervisor also became ill, then later conspired to cover up the incident, warning her that she "would lose her job if she made too big an issue out of lab safety," the suit said.
McClain said she asked for a transfer out of Lab B313 because of ongoing health concerns. Later, she discovered that a co-worker had been working next to her with "dangerous lentivirus material (similar to the AIDS virus) and embryonic stem cells on an open lab bench without biological containment."
McClain later went on medical leave, according to testimony, but continued to raise safety concerns until receiving a termination notice during her absence.
Backers of McClain have called for OSHA to reopen its investigation of the McClain case, a cause that may have received a boost from the six jurors whose verdict was read in court Thursday.
McClain's lawsuit claimed her continued exposure to genetically engineered viruses had led to a condition that triggers periodic paralysis, joint pain and fatigue. The attacks, which were particularly severe before the 52-year-old McClain started taking massive amounts of potassium, have dissipated in recent months, according to Mark McClain, the plaintiff's husband.
But McClain has said there is no known cure for the condition, adding that Pfizer, claiming protection under trademark laws, has refused to hand over records that might help her identify the virus that infected her.
L.howard@theday.com
By Lee Howard
Publication: The Day
Published 04/02/2010
Becky McClain, of Deep River, a former Pfizer scientist, won a $1.37 million judgment from a U.S. District Court jury, which found that she had been unfairly terminated after raising safety concerns.
http://www.theday.com/article/20100402/NWS02/304029903
Biotech safety verdict is hailed as a milestone; company weighs options
Becky McClain, a Deep River scientist who claims to have been infected by an experimental virus while working at Pfizer Inc.'s Groton laboratories, was awarded $1.37 million Thursday by a U.S. District Court jury in Hartford that found the company had retaliated against her and interfered with the fired worker's right to free speech.
The amount McClain receives could increase thanks to the jury's decision to also award punitive damages. The amount is up to Judge Vanessa Bryant, but typically in Connecticut punitive damages would include McClain's attorneys' fees plus an additional amount equal to the legal bills - pushing Pfizer's total penalty to more than $2.25 million.
Workers' rights organizations hailed the verdict, saying the outcome of the federal civil suit was a major milestone for biotech and nanotech workers.
"The fact that the largest drug company in the world has such contempt for the protection of their thousands of scientists is a stark warning that the present protective laws are not being enforced and need to be seriously strengthened," said Steve Zeltzer, chair of the California Coalition For Workers Memorial Day, a group that advocates for employees hurt on the job.
Pfizer continues to deny all of the suit's charges and said Thursday that the company is considering its legal options.
"We are disappointed with the verdict and do not believe the facts of this case warrant the conclusion reached by the jury," Pfizer said in an e-mailed statement.
"Pfizer is committed to protecting the health and safety of our colleagues and the communities in which we operate," the statement continued.
"In addition to our commitment to full compliance with environmental, health and safety laws and regulations, we have company-wide policies, standards, and programs combined with site-level management systems and initiatives tailored to the particular safety issues and needs at each location."
Pfizer previously said it had thoroughly investigated McClain's health and safety claims and found them to be untrue.
The suit, argued during a three-week trial before Bryant, has been followed by labor organizations, attorneys and members of the medical and research community because it is the first federal case involving a biotech worker who claims to have been harmed by a novel virus while on the job.
Workers' rights groups have criticized Bryant for throwing out McClain's major claim shortly before the trial began. The claim was that Pfizer engaged in willful and wanton misconduct in exposing her to a dangerous work environment that led to health problems, including bouts of temporary paralysis.
"The failure of the top company officials to even report to OSHA and other government agencies that many workers were getting sick numerous times in their laboratories ... is inexcusable," said Zeltzer, who called on state and federal authorities to open a criminal investigation into what he called a "cover-up" of health and safety violations at Pfizer.
McClain, a molecular biologist who first filed her suit about three years ago in New London Superior Court, had claimed that Pfizer violated whistleblower laws. A former member of the company's safety committee, McClain also charged that Pfizer violated her freedom of speech by terminating her after she pressed complaints with the U.S. Occupational Safety and Health Administration.
McClain, through her New Haven attorney Steve Fitzgerald, said in a statement that she hopes the verdict opens up a national discussion about the dangers of exposure to potentially life-threatening substances in the biotech workplace and the right of scientists and technicians to have a safe work environment.
"I was very pleased the jury found that Pfizer did retaliate against me for speaking about unsafe conditions at the Groton lab and for making a report to OSHA," McClain said. "I am disappointed, however, that I have not yet received exposure records from Pfizer" that could have identified the virus she was exposed to and provided an avenue for determining proper medical care.
Another of McClain's attorneys, Bruce E. Newman of Bristol, has called the case precedent-setting because there are few government standards regulating the bioengineering field. Worker-safety groups say OSHA regulations haven't kept up with fast-evolving technical occupations, saying the agency doesn't employ people with enough knowledge of safety problems in certain highly skilled fields.
Sunday, April 11, 2010
PFIZER CASE RAISES PROFILE OF LAB SAFETY FOR WORKERS AND PUBLIC
http://www.theday.com/article/20100411/BIZ02/304119990/-1/BIZ
By Lee Howard
Publication: The Day
Published 04/11/2010
Federal regulators' oversight of private biotech companies has been problematic
Former Pfizer Inc. scientist Becky McClain's victory in federal court this month has raised the issue of laboratory safety throughout the country, but biotech workers aren't the only potential victims of engineered viruses - the public at large should be concerned as well, some public policy and science experts say.
"The Becky McClain case is by no means isolated," Jeremy Gruber, president of the privately funded Council for Responsible Genetics in New York, said in a phone interview. "It's indicative of a systemic failure."
Gruber said that while regulators have focused on labs that deal with high-level biohazards, they have let private biotech companies operate largely unregulated, even as the engineered viruses and bacteria these lower-level facilities experiment with have become more sophisticated - and potentially more dangerous.
He added that it's "an open question" whether the types of biological material routinely used for experiments at the growing number of biotech facilities across the United States could be released into the atmosphere and cause widespread health problems.
"The potential is certainly there," he said.
But Louise Proud, head of environmental health and safety for the research and development division of Pfizer Inc., said in an interview last week at the company's New London campus that the pharmaceutical firm goes far beyond regulatory requirements in ensuring lab safety.
Proud, who oversees a staff of about 100 at various R&D campuses companywide, said "there is no impact to the community" from viruses or bacteria emanating from the Groton lab. That's because of continuous efforts to decontaminate labs by using biological hoods and filters to trap biological materials, she said, as well as bleach to clean surfaces and chemicals such as formaldehyde or, more recently, vaporized hydrogen peroxide to destroy contaminants when filters are changed.
During testimony at McClain's trial, Pfizer officials admitted that they had released foul-smelling air from one of the company's laboratories into the atmosphere near its Groton campus after several scientists, including McClain, became sick. Pfizer, which said the air had been released after being put through a filter, later buried the biological containment hood that had been tied to the foul smell, according to testimony, but McClain has raised the possibility that the apparatus - or the foul-smelling air that had been released - might have contained dangerous experimental viruses that could have posed a public health risk.
Viruses raise concern
Michael J. Siciliano, a retired professor at the University of Texas in Houston who was to be an expert witness for McClain before his testimony was barred by U.S. District Court Judge Vanessa Bryant, said in an e-mail that the types of viruses Pfizer was using at the lab could have led to "biological mayhem." He elaborated in a phone interview by saying that these viruses, which are created so as not to replicate, have the potential, when combined with other viruses, to regain their ability to reproduce, though he allowed that such a situation would be "a low-level possibility."
Testimony at McClain's trial last month indicated that the Deep River resident faced intimidation, harassment and eventual firing after complaining to the U.S. Occupational Safety & Health Administration about lab safety on Pfizer's Groton campus. A jury awarded McClain $1.37 million for what it decided were Pfizer's retaliation and interference with her right to free speech, but the New York-based pharmaceutical giant is expected to appeal the ruling.
McClain, hospitalized with back pain last Sunday after another attack of intermittent paralysis related to the virus that she believes infected her while at a Pfizer lab, had no further comment on her case, per instructions from her attorneys.
While the public-health dangers of unregulated private laboratories may have been one of the more explosive issues illuminated at McClain's trial, it was hardly the only lesson to be learned in what consumer advocate Ralph Nader termed, in a commentary on the case, the "silent violence" that scientists and lab technicians face from biohazards.
Public-policy and worker-safety advocates pointed out several other concerns the trial helped illustrate:
• The need for stronger Occupational Safety & Health Administration regulations and better enforcement of regulations, adding new protections for biotech workers who find it difficult to prove a direct cause for their injuries in a field that deals with microscopic organisms.
• The question of whether private companies such as Pfizer should be required to do risk assessments before conducting potentially dangerous experiments.
• The question of whether trade-secrets laws should supersede the need of workers to obtain records about their exposure to hazardous viruses and bacteria needed to help manage their health care.
• The question of whether companies should take a more proactive stance toward worker safety rather than abide by only their legal requirements.
Nader said McClain's trial, believed to be the first successful federal civil suit involving a biotech worker injured on the job, "promises to tear open the curtain covering hazards confronting tens of thousands of scientists and assistants in corporate and university labs doing genetic engineering work with viruses and bacteria."
OSHA faces criticism
Nader also took issue with Pfizer's "cruel refusal to give afflicted employees their own exposure records on the grounds that they are company trade secrets," saying such "alleged, bizarre property right(s)" should be trumped by concerns over the life and health of injured workers.
Adam M. Finkel, a former OSHA official who later turned agency whistle-blower, said in a statement that the McClain case "is emblematic of the utter failure of OSHA to achieve its mission."
"What happened to Becky McClain shows above all that OSHA is not an occupational health agency," said Finkel, now a faculty member at the University of Pennsylvania School of Law. "The best independent estimates of the number of premature deaths caused by occupational overexposures each year run between 40,000 and 60,000, making worker health hazards the eighth leading cause of death in the nation. And yet, OSHA devotes less than 5 percent of its resources in rule making, enforcement and education to health hazards as opposed to safety hazards."
In a telephone interview, Finkel added that he has high hopes for the future of OSHA now that David Michaels has been named to lead the agency, but he fears that the entrenched bureaucracy could make it difficult to change directions.
OSHA, in response to e-mailed questions, said "we are definitely increasing the numbers of inspection(s) conducted in the health area."
Michaels, in an interview with The New York Times, acknowledged that the McClain case has begun to show up on his radar and that he was considering improved regulation of the biotech and nanotech industries. "We do not have industry specific standards for these two industries," OSHA acknowledged in response to a request for elaboration.
Safety advocates added that OSHA will have to shore up its knowledge base as well, adding personnel who understand the complicated technologies - nanotech, involving the exploration of atomic and molecular entities to create new materials and devices; and biotech, generally dealing with the discovery of new medicines - and their potential health and safety risks.
Proud, the environmental health and safety expert at Pfizer, said she couldn't address the competencies of OSHA inspectors, but she gave assurances that agency officers regularly show up for scheduled and surprise visits - including one or two audits a year, in which policies and procedures are reviewed.
"Our doors have to always be open to OSHA," she said. "We never turn away any inspectors."
Mitigating any dangers
Proud added that, while the labs in Groton have varied configurations, she believes all of them are safe and that Pfizer goes above and beyond industry standards to ensure their workers are well protected.
Although Pfizer officials in testimony indicated they did not routinely conduct risk assessments, Proud, who has been in her current position for two years, said every Pfizer experiment is accompanied by a rigorous analysis to determine how to mitigate any experimental dangers.
These assessments - not required unless labs are receiving federal funds - are developed by committees to predict any risks that might arise from the beginning to the end of the process, she said, including how to dispose of biological waste products.
Pfizer adheres to all federal guidelines and, according to Proud, "we in many cases exceed the requirements they have in place."
Pfizer spokeswoman Liz Power pointed out that OSHA cleared the company of any wrongdoing after an extensive investigation of the McClain case, and that a judge had thrown out McClain's health claims for lack of evidence.
Gruber, the public-policy expert, said the McClain case may have illuminated problems that occurred at Pfizer seven or eight years ago, but the issue of private companies policing themselves remains a problem today.
"Pfizer is by no means the first or last place that dealt with a health and safety issue improperly," he said. "Our hope is that Becky McClain can serve as a reminder of the lack of sufficient regulation in this area."
Tuesday, March 16, 2010
PFIZER VS McCLAIN
Former employee fired for refusing to return to work, Pfizer maintains
By Lee Howard
Publication: The Day
Kazmi,Torii Courtesy of California Coalition For Worker's Memorial Day
http://www.theday.com/article/20100316/NWS02/303169892/1018
In civil case, scientist says dismissal was retaliation
Hartford - A former Pfizer Inc. scientist who accuses the pharmaceutical giant of firing her in retaliation for pressing safety complaints actually lost her job for refusing to return to work, said company attorney William J. Anthony as a much-watched civil suit opened Monday in U.S. District Court.
Becky McClain of Deep River, a molecular biologist who worked nearly a decade at Pfizer's research campus in Groton, is seeking compensation on an allegation that her former employer retaliated against her for filing Occupational Safety and Health Administration complaints.
The suit also alleges that Pfizer terminated McClain's employment because she exercised her free-speech rights in pursuing the complaints about poor safety conditions at the Groton labs that she says put her health - and that of her colleagues - at risk.
Another charge - that Pfizer engaged in willful and wanton misconduct by exposing McClain to a lentivirus that caused serious health problems and prevented her from working - was thrown out by Judge Vanessa Bryant a few weeks before the start of the civil trial.
But workers' rights organizations, at a press conference Monday in the Abraham Ribicoff Federal Building, said McClain's health allegations are integral to her case.
"We feel, in fact, that you can't separate her illness from the retaliation," said Steve Zeltzer, executive director of the California Coalition for Workers Memorial Day, a volunteer organization that tries to protect against workplace injuries and deaths. "People are getting nauseous and sick ... and not to allow this (part of the story) at this trial is a mistake."
Steve Schrag, a member of the Connecticut Council on Occupational Safety and Health, tied the McClain case to the problems that workers face across America, including the six who perished last month in the Kleen Energy plant explosion in Middletown. He pointed out that about 500 people die on the job every month - equivalent to two planes going down, without nearly the same amount of attention such events normally would incur.
"Becky McClain and the Middletown gas plant explosion are two examples of what workers face every day," Schrag said in a statement read at the press conference. "Workers are afraid to raise their voice about workplace hazards because supervisors can find a million ways to make their life miserable, including firing them."
Pfizer, in a statement issued just before the press conference, said McClain refused to return to work over an 11-month period "despite numerous and repeated efforts by Pfizer to secure her return to the workplace."
Pfizer also said OSHA concluded, after an eight-month investigation of McClain's safety-violation claims, that her complaints were "without merit."
McClain has said previously that the claims were dismissed because OSHA has weak laws regarding safety at biotech labs, which she and others allege are essentially unregulated for emerging technologies such as the stem-cell research in which she was involved.
"We have thoroughly investigated Ms. McClain's claims and our investigation concluded that her workplace was safe and that she was not infected by any virologic materials while she was employed by Pfizer," company spokeswoman Liz Power said in an e-mailed statement.
Inside the courtroom, where the six jurors and two alternates were instructed to ignore press reports of the issues surrounding the case, most of Monday's proceedings revolved around testimony by McClain's former supervisor, John Hambor of Madison, who has since left Pfizer. Hambor, who confirmed that he and McClain had been involved in a heated exchange in 2003 after which he gave her a relatively low performance review, was cited in the lawsuit as threatening her job if she made too big of an issue out of lab safety - a charge he vehemently denied.
Hambor did admit, however, to testifying falsely in a 2007 sworn deposition about whether he had been reprimanded for the incident in which McClain has claimed he used the f-word, pointed at her and backed her against a wall. Hambor originally said he did not receive a reprimand, but Monday testified that he had been reprimanded - in a written note he signed two-and-a-half years after the incident - though he admitted only to using the f-word.
Hambor did agree that something in a biological containment hood apparently had made him, McClain and another worker ill in 2002. But he said he had not expressed a desire for more testing of the lab's air after an initial test failed to identify the source of the contaminant in the containment hood that caused McClain and others to fall ill.
Larry Rose, a professor in the occupational health and safety department at the University of California at San Francisco, suspects McClain was infected with a genetically engineered lentivirus during a malfunction of the containment hood, according to a statement he released Monday.
"An adequate medical workup of Becky would have required Pfizer to release the experimental records regarding the identity of the lentivirus," he said. "Pfizer refused to release the genetic sequence information," citing, according to McClain, trademark concerns.
But issues of McClain's exposure to viruses have been largely cloaked from jurors. The judge met with attorneys for both sides for a 20-minute bench conference early in the trial, after which McClain's attorney, Bruce E. Newman, who had mentioned the use of viruses in Pfizer's labs earlier, largely steered clear of mentioning what had infected his client.
McClain, expected to begin testifying in court today, has said the virus led to periodic paralysis, joint pain and fatigue.
l.howard@theday.com
Please visit The New London Day to make comments
http://www.theday.com/article/20100316/NWS02/303169892/1018
VIDEO OF THE STORY FROM NBC
http://www.wfsb.com/video/22849297/index.html
By Lee Howard
Publication: The Day
Kazmi,Torii Courtesy of California Coalition For Worker's Memorial Day
http://www.theday.com/article/20100316/NWS02/303169892/1018
In civil case, scientist says dismissal was retaliation
Hartford - A former Pfizer Inc. scientist who accuses the pharmaceutical giant of firing her in retaliation for pressing safety complaints actually lost her job for refusing to return to work, said company attorney William J. Anthony as a much-watched civil suit opened Monday in U.S. District Court.
Becky McClain of Deep River, a molecular biologist who worked nearly a decade at Pfizer's research campus in Groton, is seeking compensation on an allegation that her former employer retaliated against her for filing Occupational Safety and Health Administration complaints.
The suit also alleges that Pfizer terminated McClain's employment because she exercised her free-speech rights in pursuing the complaints about poor safety conditions at the Groton labs that she says put her health - and that of her colleagues - at risk.
Another charge - that Pfizer engaged in willful and wanton misconduct by exposing McClain to a lentivirus that caused serious health problems and prevented her from working - was thrown out by Judge Vanessa Bryant a few weeks before the start of the civil trial.
But workers' rights organizations, at a press conference Monday in the Abraham Ribicoff Federal Building, said McClain's health allegations are integral to her case.
"We feel, in fact, that you can't separate her illness from the retaliation," said Steve Zeltzer, executive director of the California Coalition for Workers Memorial Day, a volunteer organization that tries to protect against workplace injuries and deaths. "People are getting nauseous and sick ... and not to allow this (part of the story) at this trial is a mistake."
Steve Schrag, a member of the Connecticut Council on Occupational Safety and Health, tied the McClain case to the problems that workers face across America, including the six who perished last month in the Kleen Energy plant explosion in Middletown. He pointed out that about 500 people die on the job every month - equivalent to two planes going down, without nearly the same amount of attention such events normally would incur.
"Becky McClain and the Middletown gas plant explosion are two examples of what workers face every day," Schrag said in a statement read at the press conference. "Workers are afraid to raise their voice about workplace hazards because supervisors can find a million ways to make their life miserable, including firing them."
Pfizer, in a statement issued just before the press conference, said McClain refused to return to work over an 11-month period "despite numerous and repeated efforts by Pfizer to secure her return to the workplace."
Pfizer also said OSHA concluded, after an eight-month investigation of McClain's safety-violation claims, that her complaints were "without merit."
McClain has said previously that the claims were dismissed because OSHA has weak laws regarding safety at biotech labs, which she and others allege are essentially unregulated for emerging technologies such as the stem-cell research in which she was involved.
"We have thoroughly investigated Ms. McClain's claims and our investigation concluded that her workplace was safe and that she was not infected by any virologic materials while she was employed by Pfizer," company spokeswoman Liz Power said in an e-mailed statement.
Inside the courtroom, where the six jurors and two alternates were instructed to ignore press reports of the issues surrounding the case, most of Monday's proceedings revolved around testimony by McClain's former supervisor, John Hambor of Madison, who has since left Pfizer. Hambor, who confirmed that he and McClain had been involved in a heated exchange in 2003 after which he gave her a relatively low performance review, was cited in the lawsuit as threatening her job if she made too big of an issue out of lab safety - a charge he vehemently denied.
Hambor did admit, however, to testifying falsely in a 2007 sworn deposition about whether he had been reprimanded for the incident in which McClain has claimed he used the f-word, pointed at her and backed her against a wall. Hambor originally said he did not receive a reprimand, but Monday testified that he had been reprimanded - in a written note he signed two-and-a-half years after the incident - though he admitted only to using the f-word.
Hambor did agree that something in a biological containment hood apparently had made him, McClain and another worker ill in 2002. But he said he had not expressed a desire for more testing of the lab's air after an initial test failed to identify the source of the contaminant in the containment hood that caused McClain and others to fall ill.
Larry Rose, a professor in the occupational health and safety department at the University of California at San Francisco, suspects McClain was infected with a genetically engineered lentivirus during a malfunction of the containment hood, according to a statement he released Monday.
"An adequate medical workup of Becky would have required Pfizer to release the experimental records regarding the identity of the lentivirus," he said. "Pfizer refused to release the genetic sequence information," citing, according to McClain, trademark concerns.
But issues of McClain's exposure to viruses have been largely cloaked from jurors. The judge met with attorneys for both sides for a 20-minute bench conference early in the trial, after which McClain's attorney, Bruce E. Newman, who had mentioned the use of viruses in Pfizer's labs earlier, largely steered clear of mentioning what had infected his client.
McClain, expected to begin testifying in court today, has said the virus led to periodic paralysis, joint pain and fatigue.
l.howard@theday.com
Please visit The New London Day to make comments
http://www.theday.com/article/20100316/NWS02/303169892/1018
VIDEO OF THE STORY FROM NBC
http://www.wfsb.com/video/22849297/index.html
Saturday, May 29, 2010
IN DEPTH INTERVIEW WITH BECKY McCLAIN
A Roach In The Kitchen-Interview With Injured Pfizer Molecular Biologist Becky McClain
http://www.councilforresponsiblegenetics.org/GeneWatch/GeneWatchPage.aspx?pageId=248
A ROACH IN THE KITCHEN
By CRG staff - interview with Becky McClain
After becoming seriously ill while working in a Pfizer laboratory and being denied workers' compensation, Becky McClain sued Pfizer for damages. In April, a judge awarded her $1.37 million, finding that Pfizer violated her right to free speech and her whistleblower rights. The judge dismissed McClain's claim that Pfizer's wanton misconduct had caused her to become infected by a genetically engineered virus in its labs, citing the lack of evidence. The Occupational Safety and Health Agency has told McClain that it cannot force Pfizer to turn over the exposure records that would provide this evidence, as they are protected trade secrets.
You went to court because of your own illness and Pfizer's conduct, but did you start seeing safety problems before you had any health problems yourself?
Yes. And I reported safety problems before I had any problems myself. That's what's so egregious about all this: it's not that there was an accident that I was exposed to, it's that they were careless, and willfully and wantonly disregarding appropriate safety precautions.
What were some of the big problems?
There were a lot of safety issues, but they to a large extent could have been solved by two things: either by giving us a break room with a door, with no scientific stuff going in there at all; or they could have given scientists offices outside the lab. That was a major problem. There are some labs where the dangers of exposure to materials are minimal. But when you're running a recombinant lab, bringing in genetically infectious viruses, you should use your common sense, and you shouldn't have scientists with administrative desks inside the laboratory where they are not afforded personal protection. That's just common sense.
It seems like an easy fix, too.
Pfizer reported that it would cost something like $1.6 million, and that's just ridiculous. I think they looked at how they could revamp the whole department for that cost, but all they had to do was get a six foot by ten foot room that we could share as a break room, with a door. That wouldn't cost $1.6 million.
So the break room was in the lab?
The break room was in the hallway. It was a working hallway, with biological refrigerators and freezers and people walking lab to lab carrying genetically engineered viruses, blood samples, monkey samples ... and that's where we were eating. We would find genetically engineered viruses where we were eating and drinking. We wouldn't find something every day, but I compare it to a roach in the kitchen: if you see a roach in the kitchen, you'd better know that there are a hundred roaches behind the wall. By the time you call OSHA to come in to kill that roach, it's gone.
One of the major issues was that when I was on the safety committee, I was told to stop formally documenting my safety concerns. Instead, the role of the safety committee was to perform in-house laboratory inspections. The laboratories were given advanced warning of the time and date of the inspection. So everybody had the opportunity to clean up the lab in preparation for the inspection. And so when we would do the safety inspection, we could check the box that everything's safe. Now Pfizer has all these wonderful safety inspections stating that everything's safe. But in actuality that was not the case.
We had evidence that people were getting sick shortly before and after a safety inspection, but if you look at the safety inspection report, the lab was completely safe. You see what they're doing? Pfizer was basically forcing the safety committee to do these half-bogus inspections that would create documentation that the labs were safe-but they wouldn't allow us to document anything else in between these inspections.
And this was a higher-up company policy that was handed down?
When the safety committee was formed, at the end of the meeting they gave instructions as to how we would start to perform these inspections using a form where you check boxes if the lab was in compliance. I didn't see anything wrong with that. But after that meeting, I started bringing up these additional safety issues regarding inadequate break facilities and scientists having administrative desks inside laboratories without adequate protection. But when I started bringing up these issues, some people on the safety committee stiffened up. So soon after I wrote a draft, a really rough draft, of a letter to the safety committee documenting some of these points ... and within two hours of submitting it, I get an email from management telling me to stop formally documenting these things. So what happened was that my role in the safety committee was not to report actual safety issues; it was just to conduct safety inspections. That's it.
When I went to OSHA I found that as scientists, we do not have legal rights to raise safety issues or to have the right to get them formally addressed. And you have to remember, we're working on state-of-the-art technologies. Even if we did have regulations, the regulations are going to be outdated because the science is constantly evolving. So safety forums for scientists are pertinent to ensure worker safety and public health and safety. There needs to be a formal way that scientists can get their safety issues addressed formally. This is dangerous-we're making genetically infectious viruses.
Even as other people started raising safety issues, Pfizer just ignored them. Their answer was, "We'll form a management team to address these." Three years later, they were never addressed. There's just no formal forum for scientists to raise safety issues and get them addressed, and we legally don't have the right to do that.
Do you think this is part of the reason that, although you won your case on free speech and whistleblower rights, a judge would not hear your case regarding whether you were infected in Pfizer's lab?
We had very good evidence, scientific evidence regarding the link of my illness to the exposure and the willful and wanton behavior of Pfizer. But, Pfizer was denying us pertinent exposure records necessary for us to meet the high standard of proof required by law to bring this to civil court. So in the end the judge would not allow the jury to hear the evidence regarding my illness and instead remanded it to workers comp.
If the jury would have had the opportunity to hear that count and the facts surrounding my injury, I do believe they would have ruled in my favor. Pfizer's duplicity regarding virus identities and their lack of appropriate documentation were appalling. Together with these facts and their lack of response to my safety concerns, it clearly implied willful intent. We had good evidence that the exposure caused my illness. I was hoping that my case would set a precedent for other injured biotech workers.
But the burden of proof of causation and intent required by Connecticut law is so outlandishly high and in favor of business... that no one seems to have a remote chance of bringing an egregious work-related injury claim before civil court.
And unfortunately, worker's comp brings no remedy either. Without the exposure records that Pfizer denies me, worker's comp is a dead end street. The sad part is...is that I am not alone in facing this predicament of having a work-related illness. Workers compensation is full of problems, leaving many workers abandoned with no healthcare or financial remedy for serious illness they acquired from work.
Because the burden of proof was on you, not the company?
Yes-and it should be, I'm not complaining about that. But one of the problems with the proof was that Pfizer refused to give me my exposure records.
And there is no law requiring them to give you those records?
No, there is no law under OSHA for a biotech worker to obtain the necessary exposure records needed for medical care upon a biological exposure. In fact OSHA ruled in my case that trade secrets supersede a worker's right to these records. That was one of the primary reasons why I had to file a civil claim in an attempt to obtain those records for my healthcare. So finally in civil court, the judge ordered them to give me the records, but Pfizer never gave them to us after numerous requests.
Let me back up so you know the history of what happened. I was exposed two times. The first issue was a biological hood which started making people ill. Prior to that, people were bringing genetically engineered viruses in there; and after they changed out the hood, it became recontaminated. So we didn't know: was this a biological agent that was making the hood become continually contaminated? Or was it a chemical problem? It was a mystery agent that was making people ill. I did know that people were using genetically engineered viruses, but the reason I didn't bring this up to OSHA right away is that I was told these were not human infectious viruses. I thought, oh well, I can't get sick from a non-human infectious agent anyway.
One of the other major details about the hood is that they purposely mistested the hood so that we couldn't collect adequate data for exposure.
How did they go about that?
How a hood works is that air is drawn in from where you put your hands in; 70% of the air recirculates within the hood, but 30% passes through filters and goes out the top of the hood into the lab. The exhaust is what was making people ill. When we asked Pfizer to please test the hood, because we had been getting sick for a year, they didn't bother to ask us how to test the hood. It's common sense how you would do it: air comes out the top, so where would you put the probe?
You'd put it where 30% of the air is coming out, at the top.
Right! You're not a scientist, but you get this-it's common sense!
So we got a knock on the door, and in come two men in biohazard suits. They looked like astronauts-they had respirators, oxygen tanks, everything. And they ask us to step out of the lab- can you believe this? They were all dressed up in biohazard suits, and I thought they were going to test adequately-they looked like professionals. But when we got the results back, we found they had purposely mistested. They never put the probe by the exhaust. They put the probe inside the hood, not even near the exhaust. The other thing was that we knew the contaminant was bound up in the HEPA filter in the hood, and we specifically requested that the HEPA filter be tested. All they had to do was test those filters, but they wouldn't test it. So they gave us these bogus results, and that's when my boss came up to me and pointed out the sampling error and said, "Listen, we're going to get in trouble for raising safety issues again, and I'm not going to have any part of this." He was afraid he was going to get fired.
Do you think this is why you got sick?
Where I had an etiological link to my illness was another exposure. In November of 2003, my coworker Bill Blake came up to me and asked if I knew what lentiviruses were. He had been told to work on my bench with a lentivirus experiment that he was doing. Now I'm not a virologist, I don't make genetically engineered viruses. I was making genetic expression systems that could be cloned into viruses -in layman's terms, genetic missile systems that could target a specific gene and blow it up. And Blake wasn't a virologist either. He was a tissue culture specialist, and all of a sudden he's working on these genetically engineered viruses, and he said they didn't give him any background papers, they didn't give him any training, and he didn't know exactly what this virus was. He didn't know if it was a human infectious agent!
So my understanding of lentiviruses at that time was that they were species-specific. HIV is a lentivirus, and we also were working on feline immunodeficiency viruses. Blake was working on lentiviruses with mouse embryonic stem cells, so I said, "I don't believe you could possibly be working with an HIV virus because you're working with mouse embryonic stem cells. It's got to be a mouse specific virus." But I asked him, "Could you please go check?" He had been working with this lentivirus without biocontainment on my bench for an entire month, and that was my private bench. I would at times work on that bench with my papers, doing lab reports, and I wasn't wearing gloves, so I could easily get exposed.
He came back the next day, and he did look a little bit nervous; but he said, "It's safe, but I'm supposed to decontaminate."
And did you get sick soon after he started using your bench?
I got sick exactly around the time he started using the lentivirus on my bench in October 2003, but it didn't click yet because I assumed he was telling the truth about the virus being safe and implying it was a non-human infectious agent.
As I started getting sicker and sicker, I thought, what's going on here? One doctor wrote in my report that I had some post-viral syndrome. By this time I was already on medical leave. That's when I started writing Pfizer, telling them I want the identity of these viruses that were used in my lab. I was coordinating this through OSHA now-they were advising me about how to go about doing this-but Pfizer told me to go take a hike, that no viruses were used in that lab. Well, I knew that was untrue.
Wait - they said no viruses were used in your lab?
Yes. They said that Bill Blake had never used a virus in that lab. So basically, I went to OSHA and told them Pfizer wasn't giving me the information. OSHA sent Pfizer a letter, and by law they had to tell me the identity of the biological agent. Pfizer immediately sent me the results of what Bill Blake was using. They said it was an HIV-derived lentivirus pseudotyped with VSVG. Let me explain what that is. HIV-derived lentivirus-you know what that is. It's a genetically engineered virus derived from the HIV virus. They take the HIV virus and they manipulate it-pseudotyped with VSVG, which is a virus in the rabies family which subsequently makes the HIV-derived lentivirus broadly and highly infectious.
If you are exposed to an HIV virus, you can only get it blood-to-blood. But the rabies family-you know how horribly infectious that is. It can infect through your eyes, if you breathe it in, if it gets in your mouth. So what they're doing now when they make genetically engineered viruses-and this is a BL2 lab-they can basically put a rabies-like coat on the HIV virus. Now you have an HIV-derived virus that can infect you like a rabies virus. You can imagine, as I'm working on this bench without gloves, doing paperwork ... all I have to do is touch it, put my finger in my mouth, and I'm infected.
Do you know if Bill Blake ever got sick from it?
He was all gloved up, and then he never worked on the bench again. I was the only one that I know of who was exposed to that virus.
So when I found all this out, I was just aghast. I could not believe it. And then I found out that the virus they were using in the hoods had been human infectious agents also-and they had told me they weren't! They had told me it was a mouse leukemia virus. They were bringing human infectious agents into the lab, and I was never notified.
And the people working on it, do you think they knew these were human infectious agents?
Bill Blake didn't know. He had never worked with viruses-I was really surprised that they had allowed him to do this. My boss should have known it was a human infectious agent.
At this point I'm hospitalized, and I'm getting sicker and sicker. They diagnose me with something called transient periodic paralysis, but they don't understand why I have this. Periodic paralysis is usually a genetically inherited disease. What was weird is that I don't have any of this in my family. Also, if you inherit this condition, you present at an early age -not at middle age.
I knew I had been exposed to genetically engineered viruses that were human infectious agents. They had given me the name of it, but that doesn't tell us anything. I went back to OSHA and told them that the name of a virus is not the identity of a virus. With a genetically engineered virus, each one is custom-made, and you can name it whatever you want to name it. So I went to OSHA and Pfizer and told them they needed to give me the genetic code so we could see what was in the virus and figure out why I was falling into paralysis. It took OSHA around a year to make a ruling-it went from Hartford to Boston to Washington D.C.-and they ruled that protection of trade secrets supersedes my right to get any genetic information on this virus.
That's an OSHA rule?
That was their interpretation. The OSHA law was really made for chemicals, but they're trying to apply it to biological agents, which is a little bit ridiculous.
Think about the implications for the public if workers can't get their exposure records to get medical care. You need the genetic code for medical care. Basically what you need are the cloning, sequencing and production records. The cloning records show how you make the vector, whether you're putting in a toxin, a genetic missile, or just a green fluorescent protein. This should include the sequencing records so you know that the sequence is correct. Then you need the production records. This is the part of the experiment where they take the vector that they've just cloned and they make it infectious. That's important for two reasons: first, how did they make it infectious; and second, did they test for the possibility of recombination so the virus can replicate.
You need all of these things, and I call my case the perfect storm because they couldn't snowball me. OSHA doesn't have the expertise, but I knew you needed all of these things.
OSHA called me up and told me that by law they could not assist me in obtaining the appropriate exposure records that I had requested. They said that I had to work with Pfizer and that Pfizer had agreed to give me the sequence of the viruses if I would get an attorney [to draw up a confidentiality agreement]. One of the problems that injured biotech workers have is that it's difficult to find an attorney. These are new laws, and no attorney wants to pick up a high-risk case like biotech workers. You're establishing precedent in the field, and the technology is very advanced, so the cost of litigation is very high. There are a lot of people in my same situation - not necessarily only in biotech, but there are people getting injured at work who can't find attorneys. They lose their jobs, they lose their homes ... it's really a serious issue.
It was for me too. I couldn't find an attorney. I had one, but he told me it was too complex and he couldn't help me anymore. Finally I found Bruce Newman, in my little hometown of Deep River, and he helped me for a long time.
We were able to draw up a confidentiality agreement, and I got a sequence - but it's not even a complete version of the virus. They give me this chopped up virus, and it looks like it contains errors, so I know it's a rough draft. It's still good enough that I can decode it and try to learn the function of the virus, but it's not appropriate for medical testing because it's not a finalized sequence. It's like the early rough draft of a book-you can read through and see what it's going to be about, but you can't publish it because it's full of misspellings and errors.
And listen to what I found: the virus contained a genetic missile that destroys three potassium channels and two neurotransmitters. And I've been diagnosed with a potassium-sensitive paralysis. There's the etiological link.
Still, this was from a rough draft sequence-it wasn't enough for medical testing. When biologists get exposed, they should have the right to get not just medical care, but also full disclosure of their records.
Do you feel hopeful at all that these rules could actually change, that workers could be allowed their exposure records?
There's an act in Congress called the Protecting America's Workers Act, and there's no provision in it to give employees the right to adequate exposure records for their medical care. So no, I have no hope at this point that it's going to change, since it's not in that act.
One of the problems is that there are other people this has happened to and they can't get any legal remedy. What agency is collecting data on injured biotech workers? What I'm seeing is that any incident in biotechnology is being hushed up. I think it's the biotech industry, the pharmaceutical industry, and really the scientific academic industry that do not want these things to come out. They think the public will be terrified.
Though I'm not sure it's "We don't want the public to be terrified" so much as "We don't want the public to be terrified of us."
Sure, there's self protection involved. What I saw at Pfizer, how out of control it was - there is grand potential for agents to be released into the environment.
When I went to worker's comp-because you have to go to worker's comp, they force you into it-I asked for my exposure records, and worker's comp said they don't have jurisdiction. That was it. What am I going to do without exposure records?
Then while in Worker's Comp we disclosed that I had been diagnosed with transient periodic paralysis and that we could show a causal etiological link between my condition and the Pfizer lentivirus involved in my exposure. Right after that disclosure, Pfizer wrote us a letter saying, "We're sorry, we accidentally sent you the wrong virus," and they sent sequencing for a different virus without that etiologicial link. When I asked them to send the cloning and production records to show this was the right virus, they said they didn't have those records anymore.
In your experience there, would it have been the case that those records would just disappear?
No, no, no. Can you imagine if they didn't have records of how they made human infectious agents? It's a public safety issue. This type of record keeping is standard practice in scientific research.
It doesn't seem like it would be any better for them to have the records and claim they don't than to not have the records at all.
They're both bad. There's no way out of this: it looks bad for Pfizer both ways. It shows disregard for public health and safety and for worker's healthcare rights not to have or produce those records. But it was in their best interest to play that card since it shelters them from any further legal claims as it did in my case.
This is a public health and safety issue. It's great that I won my case on freedom of speech, but this other claim, trying to get my exposure records, is very serious too, and there's no avenue available to pursue it.
Biotech workers had better watch out. The best thing is to take safety very seriously and prevent these things from happening. The problem is, at Pfizer we were trying to prevent them from happening-and we were told to shut up. If it happens at the wealthiest pharmaceutical company in the world, it can happen elsewhere.
http://www.councilforresponsiblegenetics.org/GeneWatch/GeneWatchPage.aspx?pageId=248
A ROACH IN THE KITCHEN
By CRG staff - interview with Becky McClain
After becoming seriously ill while working in a Pfizer laboratory and being denied workers' compensation, Becky McClain sued Pfizer for damages. In April, a judge awarded her $1.37 million, finding that Pfizer violated her right to free speech and her whistleblower rights. The judge dismissed McClain's claim that Pfizer's wanton misconduct had caused her to become infected by a genetically engineered virus in its labs, citing the lack of evidence. The Occupational Safety and Health Agency has told McClain that it cannot force Pfizer to turn over the exposure records that would provide this evidence, as they are protected trade secrets.
You went to court because of your own illness and Pfizer's conduct, but did you start seeing safety problems before you had any health problems yourself?
Yes. And I reported safety problems before I had any problems myself. That's what's so egregious about all this: it's not that there was an accident that I was exposed to, it's that they were careless, and willfully and wantonly disregarding appropriate safety precautions.
What were some of the big problems?
There were a lot of safety issues, but they to a large extent could have been solved by two things: either by giving us a break room with a door, with no scientific stuff going in there at all; or they could have given scientists offices outside the lab. That was a major problem. There are some labs where the dangers of exposure to materials are minimal. But when you're running a recombinant lab, bringing in genetically infectious viruses, you should use your common sense, and you shouldn't have scientists with administrative desks inside the laboratory where they are not afforded personal protection. That's just common sense.
It seems like an easy fix, too.
Pfizer reported that it would cost something like $1.6 million, and that's just ridiculous. I think they looked at how they could revamp the whole department for that cost, but all they had to do was get a six foot by ten foot room that we could share as a break room, with a door. That wouldn't cost $1.6 million.
So the break room was in the lab?
The break room was in the hallway. It was a working hallway, with biological refrigerators and freezers and people walking lab to lab carrying genetically engineered viruses, blood samples, monkey samples ... and that's where we were eating. We would find genetically engineered viruses where we were eating and drinking. We wouldn't find something every day, but I compare it to a roach in the kitchen: if you see a roach in the kitchen, you'd better know that there are a hundred roaches behind the wall. By the time you call OSHA to come in to kill that roach, it's gone.
One of the major issues was that when I was on the safety committee, I was told to stop formally documenting my safety concerns. Instead, the role of the safety committee was to perform in-house laboratory inspections. The laboratories were given advanced warning of the time and date of the inspection. So everybody had the opportunity to clean up the lab in preparation for the inspection. And so when we would do the safety inspection, we could check the box that everything's safe. Now Pfizer has all these wonderful safety inspections stating that everything's safe. But in actuality that was not the case.
We had evidence that people were getting sick shortly before and after a safety inspection, but if you look at the safety inspection report, the lab was completely safe. You see what they're doing? Pfizer was basically forcing the safety committee to do these half-bogus inspections that would create documentation that the labs were safe-but they wouldn't allow us to document anything else in between these inspections.
And this was a higher-up company policy that was handed down?
When the safety committee was formed, at the end of the meeting they gave instructions as to how we would start to perform these inspections using a form where you check boxes if the lab was in compliance. I didn't see anything wrong with that. But after that meeting, I started bringing up these additional safety issues regarding inadequate break facilities and scientists having administrative desks inside laboratories without adequate protection. But when I started bringing up these issues, some people on the safety committee stiffened up. So soon after I wrote a draft, a really rough draft, of a letter to the safety committee documenting some of these points ... and within two hours of submitting it, I get an email from management telling me to stop formally documenting these things. So what happened was that my role in the safety committee was not to report actual safety issues; it was just to conduct safety inspections. That's it.
When I went to OSHA I found that as scientists, we do not have legal rights to raise safety issues or to have the right to get them formally addressed. And you have to remember, we're working on state-of-the-art technologies. Even if we did have regulations, the regulations are going to be outdated because the science is constantly evolving. So safety forums for scientists are pertinent to ensure worker safety and public health and safety. There needs to be a formal way that scientists can get their safety issues addressed formally. This is dangerous-we're making genetically infectious viruses.
Even as other people started raising safety issues, Pfizer just ignored them. Their answer was, "We'll form a management team to address these." Three years later, they were never addressed. There's just no formal forum for scientists to raise safety issues and get them addressed, and we legally don't have the right to do that.
Do you think this is part of the reason that, although you won your case on free speech and whistleblower rights, a judge would not hear your case regarding whether you were infected in Pfizer's lab?
We had very good evidence, scientific evidence regarding the link of my illness to the exposure and the willful and wanton behavior of Pfizer. But, Pfizer was denying us pertinent exposure records necessary for us to meet the high standard of proof required by law to bring this to civil court. So in the end the judge would not allow the jury to hear the evidence regarding my illness and instead remanded it to workers comp.
If the jury would have had the opportunity to hear that count and the facts surrounding my injury, I do believe they would have ruled in my favor. Pfizer's duplicity regarding virus identities and their lack of appropriate documentation were appalling. Together with these facts and their lack of response to my safety concerns, it clearly implied willful intent. We had good evidence that the exposure caused my illness. I was hoping that my case would set a precedent for other injured biotech workers.
But the burden of proof of causation and intent required by Connecticut law is so outlandishly high and in favor of business... that no one seems to have a remote chance of bringing an egregious work-related injury claim before civil court.
And unfortunately, worker's comp brings no remedy either. Without the exposure records that Pfizer denies me, worker's comp is a dead end street. The sad part is...is that I am not alone in facing this predicament of having a work-related illness. Workers compensation is full of problems, leaving many workers abandoned with no healthcare or financial remedy for serious illness they acquired from work.
Because the burden of proof was on you, not the company?
Yes-and it should be, I'm not complaining about that. But one of the problems with the proof was that Pfizer refused to give me my exposure records.
And there is no law requiring them to give you those records?
No, there is no law under OSHA for a biotech worker to obtain the necessary exposure records needed for medical care upon a biological exposure. In fact OSHA ruled in my case that trade secrets supersede a worker's right to these records. That was one of the primary reasons why I had to file a civil claim in an attempt to obtain those records for my healthcare. So finally in civil court, the judge ordered them to give me the records, but Pfizer never gave them to us after numerous requests.
Let me back up so you know the history of what happened. I was exposed two times. The first issue was a biological hood which started making people ill. Prior to that, people were bringing genetically engineered viruses in there; and after they changed out the hood, it became recontaminated. So we didn't know: was this a biological agent that was making the hood become continually contaminated? Or was it a chemical problem? It was a mystery agent that was making people ill. I did know that people were using genetically engineered viruses, but the reason I didn't bring this up to OSHA right away is that I was told these were not human infectious viruses. I thought, oh well, I can't get sick from a non-human infectious agent anyway.
One of the other major details about the hood is that they purposely mistested the hood so that we couldn't collect adequate data for exposure.
How did they go about that?
How a hood works is that air is drawn in from where you put your hands in; 70% of the air recirculates within the hood, but 30% passes through filters and goes out the top of the hood into the lab. The exhaust is what was making people ill. When we asked Pfizer to please test the hood, because we had been getting sick for a year, they didn't bother to ask us how to test the hood. It's common sense how you would do it: air comes out the top, so where would you put the probe?
You'd put it where 30% of the air is coming out, at the top.
Right! You're not a scientist, but you get this-it's common sense!
So we got a knock on the door, and in come two men in biohazard suits. They looked like astronauts-they had respirators, oxygen tanks, everything. And they ask us to step out of the lab- can you believe this? They were all dressed up in biohazard suits, and I thought they were going to test adequately-they looked like professionals. But when we got the results back, we found they had purposely mistested. They never put the probe by the exhaust. They put the probe inside the hood, not even near the exhaust. The other thing was that we knew the contaminant was bound up in the HEPA filter in the hood, and we specifically requested that the HEPA filter be tested. All they had to do was test those filters, but they wouldn't test it. So they gave us these bogus results, and that's when my boss came up to me and pointed out the sampling error and said, "Listen, we're going to get in trouble for raising safety issues again, and I'm not going to have any part of this." He was afraid he was going to get fired.
Do you think this is why you got sick?
Where I had an etiological link to my illness was another exposure. In November of 2003, my coworker Bill Blake came up to me and asked if I knew what lentiviruses were. He had been told to work on my bench with a lentivirus experiment that he was doing. Now I'm not a virologist, I don't make genetically engineered viruses. I was making genetic expression systems that could be cloned into viruses -in layman's terms, genetic missile systems that could target a specific gene and blow it up. And Blake wasn't a virologist either. He was a tissue culture specialist, and all of a sudden he's working on these genetically engineered viruses, and he said they didn't give him any background papers, they didn't give him any training, and he didn't know exactly what this virus was. He didn't know if it was a human infectious agent!
So my understanding of lentiviruses at that time was that they were species-specific. HIV is a lentivirus, and we also were working on feline immunodeficiency viruses. Blake was working on lentiviruses with mouse embryonic stem cells, so I said, "I don't believe you could possibly be working with an HIV virus because you're working with mouse embryonic stem cells. It's got to be a mouse specific virus." But I asked him, "Could you please go check?" He had been working with this lentivirus without biocontainment on my bench for an entire month, and that was my private bench. I would at times work on that bench with my papers, doing lab reports, and I wasn't wearing gloves, so I could easily get exposed.
He came back the next day, and he did look a little bit nervous; but he said, "It's safe, but I'm supposed to decontaminate."
And did you get sick soon after he started using your bench?
I got sick exactly around the time he started using the lentivirus on my bench in October 2003, but it didn't click yet because I assumed he was telling the truth about the virus being safe and implying it was a non-human infectious agent.
As I started getting sicker and sicker, I thought, what's going on here? One doctor wrote in my report that I had some post-viral syndrome. By this time I was already on medical leave. That's when I started writing Pfizer, telling them I want the identity of these viruses that were used in my lab. I was coordinating this through OSHA now-they were advising me about how to go about doing this-but Pfizer told me to go take a hike, that no viruses were used in that lab. Well, I knew that was untrue.
Wait - they said no viruses were used in your lab?
Yes. They said that Bill Blake had never used a virus in that lab. So basically, I went to OSHA and told them Pfizer wasn't giving me the information. OSHA sent Pfizer a letter, and by law they had to tell me the identity of the biological agent. Pfizer immediately sent me the results of what Bill Blake was using. They said it was an HIV-derived lentivirus pseudotyped with VSVG. Let me explain what that is. HIV-derived lentivirus-you know what that is. It's a genetically engineered virus derived from the HIV virus. They take the HIV virus and they manipulate it-pseudotyped with VSVG, which is a virus in the rabies family which subsequently makes the HIV-derived lentivirus broadly and highly infectious.
If you are exposed to an HIV virus, you can only get it blood-to-blood. But the rabies family-you know how horribly infectious that is. It can infect through your eyes, if you breathe it in, if it gets in your mouth. So what they're doing now when they make genetically engineered viruses-and this is a BL2 lab-they can basically put a rabies-like coat on the HIV virus. Now you have an HIV-derived virus that can infect you like a rabies virus. You can imagine, as I'm working on this bench without gloves, doing paperwork ... all I have to do is touch it, put my finger in my mouth, and I'm infected.
Do you know if Bill Blake ever got sick from it?
He was all gloved up, and then he never worked on the bench again. I was the only one that I know of who was exposed to that virus.
So when I found all this out, I was just aghast. I could not believe it. And then I found out that the virus they were using in the hoods had been human infectious agents also-and they had told me they weren't! They had told me it was a mouse leukemia virus. They were bringing human infectious agents into the lab, and I was never notified.
And the people working on it, do you think they knew these were human infectious agents?
Bill Blake didn't know. He had never worked with viruses-I was really surprised that they had allowed him to do this. My boss should have known it was a human infectious agent.
At this point I'm hospitalized, and I'm getting sicker and sicker. They diagnose me with something called transient periodic paralysis, but they don't understand why I have this. Periodic paralysis is usually a genetically inherited disease. What was weird is that I don't have any of this in my family. Also, if you inherit this condition, you present at an early age -not at middle age.
I knew I had been exposed to genetically engineered viruses that were human infectious agents. They had given me the name of it, but that doesn't tell us anything. I went back to OSHA and told them that the name of a virus is not the identity of a virus. With a genetically engineered virus, each one is custom-made, and you can name it whatever you want to name it. So I went to OSHA and Pfizer and told them they needed to give me the genetic code so we could see what was in the virus and figure out why I was falling into paralysis. It took OSHA around a year to make a ruling-it went from Hartford to Boston to Washington D.C.-and they ruled that protection of trade secrets supersedes my right to get any genetic information on this virus.
That's an OSHA rule?
That was their interpretation. The OSHA law was really made for chemicals, but they're trying to apply it to biological agents, which is a little bit ridiculous.
Think about the implications for the public if workers can't get their exposure records to get medical care. You need the genetic code for medical care. Basically what you need are the cloning, sequencing and production records. The cloning records show how you make the vector, whether you're putting in a toxin, a genetic missile, or just a green fluorescent protein. This should include the sequencing records so you know that the sequence is correct. Then you need the production records. This is the part of the experiment where they take the vector that they've just cloned and they make it infectious. That's important for two reasons: first, how did they make it infectious; and second, did they test for the possibility of recombination so the virus can replicate.
You need all of these things, and I call my case the perfect storm because they couldn't snowball me. OSHA doesn't have the expertise, but I knew you needed all of these things.
OSHA called me up and told me that by law they could not assist me in obtaining the appropriate exposure records that I had requested. They said that I had to work with Pfizer and that Pfizer had agreed to give me the sequence of the viruses if I would get an attorney [to draw up a confidentiality agreement]. One of the problems that injured biotech workers have is that it's difficult to find an attorney. These are new laws, and no attorney wants to pick up a high-risk case like biotech workers. You're establishing precedent in the field, and the technology is very advanced, so the cost of litigation is very high. There are a lot of people in my same situation - not necessarily only in biotech, but there are people getting injured at work who can't find attorneys. They lose their jobs, they lose their homes ... it's really a serious issue.
It was for me too. I couldn't find an attorney. I had one, but he told me it was too complex and he couldn't help me anymore. Finally I found Bruce Newman, in my little hometown of Deep River, and he helped me for a long time.
We were able to draw up a confidentiality agreement, and I got a sequence - but it's not even a complete version of the virus. They give me this chopped up virus, and it looks like it contains errors, so I know it's a rough draft. It's still good enough that I can decode it and try to learn the function of the virus, but it's not appropriate for medical testing because it's not a finalized sequence. It's like the early rough draft of a book-you can read through and see what it's going to be about, but you can't publish it because it's full of misspellings and errors.
And listen to what I found: the virus contained a genetic missile that destroys three potassium channels and two neurotransmitters. And I've been diagnosed with a potassium-sensitive paralysis. There's the etiological link.
Still, this was from a rough draft sequence-it wasn't enough for medical testing. When biologists get exposed, they should have the right to get not just medical care, but also full disclosure of their records.
Do you feel hopeful at all that these rules could actually change, that workers could be allowed their exposure records?
There's an act in Congress called the Protecting America's Workers Act, and there's no provision in it to give employees the right to adequate exposure records for their medical care. So no, I have no hope at this point that it's going to change, since it's not in that act.
One of the problems is that there are other people this has happened to and they can't get any legal remedy. What agency is collecting data on injured biotech workers? What I'm seeing is that any incident in biotechnology is being hushed up. I think it's the biotech industry, the pharmaceutical industry, and really the scientific academic industry that do not want these things to come out. They think the public will be terrified.
Though I'm not sure it's "We don't want the public to be terrified" so much as "We don't want the public to be terrified of us."
Sure, there's self protection involved. What I saw at Pfizer, how out of control it was - there is grand potential for agents to be released into the environment.
When I went to worker's comp-because you have to go to worker's comp, they force you into it-I asked for my exposure records, and worker's comp said they don't have jurisdiction. That was it. What am I going to do without exposure records?
Then while in Worker's Comp we disclosed that I had been diagnosed with transient periodic paralysis and that we could show a causal etiological link between my condition and the Pfizer lentivirus involved in my exposure. Right after that disclosure, Pfizer wrote us a letter saying, "We're sorry, we accidentally sent you the wrong virus," and they sent sequencing for a different virus without that etiologicial link. When I asked them to send the cloning and production records to show this was the right virus, they said they didn't have those records anymore.
In your experience there, would it have been the case that those records would just disappear?
No, no, no. Can you imagine if they didn't have records of how they made human infectious agents? It's a public safety issue. This type of record keeping is standard practice in scientific research.
It doesn't seem like it would be any better for them to have the records and claim they don't than to not have the records at all.
They're both bad. There's no way out of this: it looks bad for Pfizer both ways. It shows disregard for public health and safety and for worker's healthcare rights not to have or produce those records. But it was in their best interest to play that card since it shelters them from any further legal claims as it did in my case.
This is a public health and safety issue. It's great that I won my case on freedom of speech, but this other claim, trying to get my exposure records, is very serious too, and there's no avenue available to pursue it.
Biotech workers had better watch out. The best thing is to take safety very seriously and prevent these things from happening. The problem is, at Pfizer we were trying to prevent them from happening-and we were told to shut up. If it happens at the wealthiest pharmaceutical company in the world, it can happen elsewhere.
RETROVIRUSES, GENETIC ENGINEERING & PUBLIC & WORKER SAFETY
GIVE THEM AN INCH... "Pfizer's head of biosafety, Dr. Eric Utt, admitted that no risk assessment had been conducted on the potentially dangerous lentivirus experiment conducted in Mrs. McClain's workspace-or, in fact, for lentivirus experiments in general."
http://www.councilforresponsiblegenetics.org/GeneWatch/GeneWatchPage.aspx?pageId=251
GIVE THEM AN INCH...
By Michael Siciliano
I was scheduled to appear as an expert witness at Becky McClain's trial against Pfizer. My testimony was to be that the symptoms of Mrs. McClain's illness were consistent with her being exposed to a virus being worked on in the laboratory. In the judge's opinion, the lack of physical evidence relating any such exposure to the disease was considered insufficient and the related count was thrown out. However, I was confident that I could testify on biosafety issues-I am well practiced in the art of biosafety, having run a molecular genetics and cell biology laboratory for over 35 years in which biosafety considerations were carefully met. I did have concern about how flawed Pfizer's biosafety practices could really be.
Pfizer claimed that Mrs. McClain was terminated for not returning to work after she took a leave due to her illness; Mrs. McClain said that she was fearful about returning to work because of the lax and dangerous biosafety practices at Pfizer. I could not imagine that Pfizer was lax in that area because a former Pfizer research director I knew assured me that the Standard Operating Procedures for Pfizer were to follow the National Institutes of Health guidelines for biosafety when dealing with recombinant DNA activity.
I was shocked to learn that Pfizer's own guidelines for appropriate procedure, as well as NIH guidelines, were not followed in Mrs. McClain's department and that she had a real basis for her fear in returning to work. In some cases the lack of safety standards appeared to be due to ignorance and in others it appeared to be due to an apparent flagrant disregard for world-recognized appropriate procedure.
The problem proved to be systemic: Pfizer's head of biosafety, Dr. Eric Utt, admitted that no risk assessment had been conducted on the potentially dangerous lentivirus experiment conducted in Mrs. McClain's workspace-or, in fact, for lentivirus experiments in general. Why would no risk assessment be done when it is such a fundamental procedure before initiating any such experiments with potentially biohazardous material as a lentivirus? Dr. Utt answered that such assessment is already done on the kits they get that contain the reagents for the experiment. This is a monstrously frightening statement, coming from one at such a lofty position in the organization with respect to biosafety.
So what's the big deal?
The lentivirus which McClain was exposed is a retrovirus. This means its genetic code is in the form of RNA rather than DNA. The RNA is in a "coat" which enables it to attach to a broad spectrum of mammalian cells and become engulfed in the cell. As described by the late brilliant Nobel-prize winning molecular geneticist Howard Temin, the virus has a gene (called reverse transcriptase or RET) which enables it to go backwards in the genetic paradigm. Normally, the DNA code for a gene creates an RNA message which directs the formation of the protein specified by the gene. RET makes it possible to go backwards, making DNA from the RNA. The viral DNA can then be inserted into the DNA of the chromosomes. New gene insertion with long term effects becomes possible, depending on what the virus has been designed to do. The gene therapy possibilities are intoxicating to drug companies and biomedical research. We can expect increased intensity in this field in the near future.
Temin suggested that making the virus replication deficient might be a safe form of gene therapy. However, we have now learned that a replication deficient virus, such as what Pfizer was using, can recombine with other viruses in its environment, or in the cell into which it is transduced, to become competent. From there it can replicate itself millions of times and create severe disease scenarios.
That is not the only problem these genetically engineered viruses can cause. Upon insertion into host cell DNA the virus can cause mutations at the sites of insertion that lead to cancer. These events, including recovery of replication competence, have been described in monkeys and in humans undergoing initial gene therapies, resulting in approximately 30% of subjects treated dying of lymphoma.
In a proper Risk Assessment, one needs to determine not only the genes in the virus being used, but also the spectrum of infectivity of its coat as well as the concentration of the virus being used. It is also necessary to consider the mammalian cells being transduced. They may be harboring other viruses in various cellular regions or have their sequences integrated into its chromosomes. These are all targets for recombination which can generate a replication-competent virus. Such issues cannot be addressed in a commercially available reagent kit disclaimer since the specifics of the virus, its concentration, and cells into which they are being transduced are not considered. These parameters need to be articulated in a Risk Assessment sent to the Institutional Biosafety Committee, which needs to give final approval for the experiment depending on its perceived risk/benefit ratio and indicating the conditions under which such an experiment can be performed. That is the only acceptable NIH approved procedure.
Later I had the opportunity to speak with Dr. Utt. I told him that he needed to know that his Risk Assessment was not consistent with NIH guidelines on biosafety. He smiled and said that Pfizer was not bound to follow NIH guidelines.
He was right. An academic institution must follow NIH rules or lose their funding for their projects-all the projects at the institution. Drug companies don't get NIH funding, so their guidelines are as effective as traffic signs in Italy: mere suggestions.
The time has come for new law. The number of biotech workers is growing, and we can expect increased involvement from big pharma. Workers need legal rights to obtain disclosure of the identity of the biological agents to which they are exposed in order to obtain directed medical care. Unless biotechnology labs are brought under appropriate regulation, severe threats persist for the welfare of workers in the industry as well as the general public.
Michael J. Siciliano, Ph.D., D.Sc.(hon), was Kenneth D. Muller Professor of Tumor Genetics (Ret.) at The University of Texas M.D. Anderson Cancer Center.
Subscribe to:
Posts (Atom)

